Valeur20212022202320242025Total du passif———68.61 M69.14 MTotal des capitaux propres———134.02 M62.3 MTotal du passif et des capitaux propres———202.63 M131.44 MDette totale—————Dette nette—————
Silence Therapeutics Plc - American Depository Share
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.